Proteomic and Mitochondrial Genomic Analyses of Pediatric Brain Tumors

Molecular Neurobiology

Volumn 52, Issue 3, 2015, Pages 1341-1363

  Luna, Brenda ^a   Bhatia, Sanjiv ^b   Yoo, Changwon ^a   Felty, Quentin ^a   Sandberg, David I ^c   Duchowny, Michael ^b   Khatib, Ziad ^b   Miller, Ian ^b   Ragheb, John ^b   Prasanna, Jayakar ^b   Roy, Deodutta ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b MIAMI CHILDREN'S HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Childhood brain tumors; Mitochondrial dysfunction; Mitochondrial genome; Tumor proteome

Indexed keywords

BETA POLYPEPTIDE 2 LIKE 1; C10ORF2 PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; DNA HELICASE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN ISOFORM 2; GUANINE NUCLEOTIDE BINDING PROTEIN; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 BETA; HISTONE H2B; LIGHT POLYPEPTIDE 68; LIPOCORTIN 1; MITOCHONDRIAL DNA; PEPTIDES AND PROTEINS; PHOSPHOSERINE; PHOSPHOSERINE AMINOTRANSFERASE ISOFORM 1; POLYPEPTIDE; RAN PROTEIN; SIRTUIN 2; UNCLASSIFIED DRUG; DNA; PROTEOME; TUMOR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BAYES THEOREM; BIOGENESIS; BRAIN TUMOR; CANCER RISK; CARCINOGENESIS; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA DAMAGE; DNA SEQUENCE; DOWN REGULATION; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOMICS; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOCHONDRIAL GENOME; MITOCHONDRION; MONTE CARLO METHOD; NEUROFILAMENT; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SCHOOL CHILD; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION; BIOLOGICAL MODEL; COMPARATIVE STUDY; EPILEPSY; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION; OXIDATIVE STRESS; REAL TIME POLYMERASE CHAIN REACTION; RISK; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DNA DAMAGE; DNA, MITOCHONDRIAL; DNA, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPILEPSY; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOME, MITOCHONDRIAL; HUMANS; MALE; MODELS, BIOLOGICAL; MUTATION; NEOPLASM PROTEINS; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEOME; REAL-TIME POLYMERASE CHAIN REACTION; RISK; SEX FACTORS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84942818250     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8930-3     Document Type: Article

References (56)

1. Gurney JG, Smith MA, Bunin GR (1999a) CNS and miscellaneous intracranial and intraspinal neoplasms (ICCC III). In: Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649
2. Gurney JG, Wall DA, Jukich PJ, Davis FG (1999) The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States. Cancer Causes Control 10:101–105
3. Kunkle B, Sandberg DI, Jayakar P, Felty Q, Roy D (2010) Gene–environment interaction and susceptibility to pediatric brain tumors. In: Roy D and Dorak MT (eds) Environmental factors, genes, and the development of human cancers, 223–252
4. Kunkle B, Sandberg DI, Jayakar P, Felty Q, Roy D (2011) Environment, genetic and epigenetic alterations and pediatric central nervous system tumors. Encycl Env Health 2:559–568
5. Kunkle B, Bae S, Singh KP, Roy D (2014) Increased risk of childhood brain tumors among children whose parents had farm related pesticide exposures during pregnancy. JP J Biostat, in press
6. Erecinska M, Cherian S, Silver IA (2004) Energy metabolism in mammalian brain during development. Prog Neurobiol 73:397–445
7. Lerman-Sagie T, Leshinsky-Silver E, Watemberg N, Luckman Y, Lev D (2005) White matter involvement in mitochondrial diseases. Mol Genet Metab 84:127–136
8. Buonocore G, Perrone S, Bracci R (2001) Free radicals and brain damage in the newborn. Biol Neonate 79:180–186
9. Ohta S (2006) Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs. Oncogene 25:4768–4776
10. Kulawiec M, Safina A, Desouki MM, Still I, Matsui SI, Bakin A, Singh KK (2008) Tumorigenic transformation of human breast epithelial cells induced by mitochondrial DNA depletion. Cancer Biol Ther 7:1732–1743
11. Roy D, Felty Q, Narayan S, Jayakar P (2007) Signature of mitochondria of steroidal hormones-dependent normal and cancer cells: potential molecular targets for cancer therapy. Front Biosci 12:154–173
12. Felty Q (2010) Proteomic 2-D DIGE profiling of human vascular endothelial cells exposed to environmentally relevant concentration of endocrine disruptor PCB153 and physiological concentration of 17β-estradiol. Cell Biol Toxicol 27:49–68
13. Luna B, Bhatia B, Yoo C, Felty Q, Sandberg DI, Duchowny M, Khatib Z, Miller I, Ragheb J, Prasanna J, Roy D (2014) Bayesian network and mechanistic hierarchical structure modeling of increased likelihood of developing intractable childhood epilepsy from the combined effect of mtDNA variants, oxidative damage, and copy number. J Mol Neurosci, in press
14. Ayala-Torres S, Chen Y, Svoboda T, Rosenblatt J, Van Houten B (2000) Analysis of gene-specific DNA damage and repair using quantitative polymerase chain reaction. Methods 22:135–147
15. Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ (2007) Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67:4687–4694
16. Kunkle BW, Yoo C, Roy D (2013) Reverse engineering of modified genes by Bayesian network analysis defines molecular determinants critical to the development of glioblastoma. PLoS ONE 8:e64140
17. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds) (2010) SEER cancer statistics review, 1975–2008. National Cancer Institute, Bethesda, http://seer.cancer.gov/csr/1975_2008/
18. El-Hattab AW, Scaglia F (2013) Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapy 10:186–198
19. Hashimoto Y, Akiyama Y, Yuasa Y (2013) Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer. PLoS ONE 8:e62589
20. Tahimic CG, Tomimatsu N, Nishigaki R, Fukuhara A, Toda T et al (2006) Evidence for a role of Collapsin response mediator protein-2 in signaling pathways that regulate the proliferation of non-neuronal cells. Biochem Biophys Res Commun 340:1244–1250
21. Hart CE, Race V, Achouri Y, Wiame E, Sharrard M, Olpin SE, Watkinson J, Bonham JR, Jaeken J, Matthijs G, Van Schaftingen E (2007) Phosphoserine aminotransferase deficiency: a novel disorder of the serine biosynthesis pathway. Am J Hum Genet 80:931–937
22. Vie N, Copois V, Bascoul-Mollevi C, Denis V, Bec N, Robert B, Fraslon C, Conseiller E, Molina F, Larroque C, Martineau P, Del Rio M, Gongora C (2008) Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells. Mol Cancer 7:14
23. Toyama A, Suzuki A, Shimada T, Aoki C, Aoki Y, Umino Y, Nakamura Y, Aoki D, Sato TA (2012) Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers. Cancer Sci 103:747–755
24. Amelio I, Cutruzzolá F, Antonov A, Agostini M, Melino G (2014) Serine and glycine metabolism in cancer. Trends Biochem Sci 39:191–198
25. Guedes-Dias P, Oliveira JMA (2013) Lysine deacetylases and mitochondrial dynamics in neurodegeneration. Biochem Biophys Acta 1832:1345–1359
26. Garcia Pedrero JM, Fernandez MP, Morgan RO, Herrero Zapatero A, Gonzalez MV, Suarez Nieto C, Rodrigo JP (2004) Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 164:73–79
27. McArthur S, Cristante E, Paterno M, Christian H, Roncaroli F, Gillies GE, Solito E (2010) Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia. J Immunol 185:6317–6328
28. Barton VN, Donson AM, Kleinschmidt-DeMasters BK, Birks DK, Handler MH, Foreman NK (2010) Unique molecular characteristics of pediatric myxopapillary ependymoma. Brain Pathol 20:560–570
29. Andreiuolo F, Puget S, Peyre M, Dantas-Barbosa C, Boddaert N, Philippe C, Mauguen A, Grill J, Varlet P (2010) Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas. Neuronal Oncol 12:1126–1234
30. Hagel C, Treszl A, Fehlert J, Harder J, von Haxthausen F, Kern M, von Bueren AO, Kordes U (2013) Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression. J Neurooncol 112:191–197
31. Bodey B, Cosgrove M, Gonzalez-Gomez I, Siegel SE, Martin SE, Gilles FH (1991) Co-expression of four intermediate filament subclasses in childhood glial neoplasms. Mod Pathol 4:742–749
32. Shahim P, Darin N, Andreasson U, Blennow K, Jennions E, Lundgren J, Månsson JE, Naess K, Törnhage CJ, Zetterberg H, Mattsson N (2013) Cerebrospinal fluid brain injury biomarkers in children: a multicenter study. Pediatr Neurol 49:31–39
33. Phillips HS, Kharbanda S, Chen R et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 3:157–173
34. Varlet P, Soni D, Miquel C, Roux FX, Meder JF, Chneiweiss H, Daumas-Duport C (2004) New variants of malignant glioneuronal tumors: a clinicopathological study of 40 cases. Neurosurgery 55:1377–1391
35. Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, Mawrin C, Dietzmann K (2001) High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer 93:534–538
36. Kurtz A, Lueth M, Kluwe L, Zhang T, Foster R, Mautner VF, Hartmann M, Tan DJ, Martuza RL, Friedrich RE, Driever PH, Wong LJ (2004) Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors. Mol Cancer Res 2:433–441
37. Montanini L, Regna-Gladin C, Eoli M, Albarosa R, Carrara F, Zeviani M, Bruzzone MG, Broggi G, Boiardi A, Finocchiaro G (2005) Instability of mitochondrial DNA and MRI and clinical correlations in malignant gliomas. J Neurooncol 74:87–89
38. Kirches E, Michael M, Woy C, Schneider T, Warich-Kirches M, Schneider-Stock R, Winkler K, Wittig H, Dietzmann K (1999) Loss of heteroplasmy in the displacement loop of brain mitochondrial DNA in astrocytic tumors. Genes chromosomes. Cancer 26:80–83
39. Vega A, Salas A, Gamborino E, Sobrido MJ, Carracedo A, Macaulay V (2004) mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations. Oncogene 23:1314–1320
40. Kiebish MA, Seyfried TN (2005) Absence of pathogenic mitochondrial DNA mutations in mouse brain tumors. BMC Cancer 5:102
41. Hanna M, Nelson P, Rahman S, Lane RJM, Land L, Heales S, Cooper MJ, Schapira AHV, Morgan-Hughes JA, Wood NW (1998) Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA. Am J Genet 63:29–36
42. Felty Q, Roy D (2005) Estrogen, mitochondria, and growth of cancer and non-cancer cells. J Carcinog 4:e1
43. Dickinson A, Yeung KY, Donoghue J, Baker MJ, Kelly RDW, McKenzie M, Johns TG, St. John JC (2013) The regulation of mitochondrial DNA copy number in glioblastoma cells. Cell Death Differ 20:1644–1653
44. Lee H, Wei Y (2005) Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol 37:822–834
45. Lee H, Yin P, Lu C, Chi CW, Wei YH (2000) Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem J 348:425–432
46. Malakhova L, Bezlepkin V, Antipova V, Ushakova T, Fomenko L, Sirota N, Gaziev AI (2005) The increase in mitochondrial DNA copy number in the tissue of γ-irradiated mice. Cell Mol Biol Lett 10:721–732
47. Modica-Napolitano JS, Singh KK (2002) Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med 4:1–19
48. Astuti D, Latif F, Dallol A, Dahia PL, Douglas F, George E, Sköldberg F, Husebye ES, Eng C, Maher ER (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69:49–54
49. Alam NA, Rowan AJ, Wortham NC, Pollard PJ, Mitchell M, Tyrer JP, Barclay E, Calonje E, Manek S, Adams SJ, Bowers PW, Burrows NP, Charles-Holmes R, Cook LJ, Daly BM, Ford GP, Fuller LC, Hadfield-Jones SE, Hardwick N, Highet AS, Keefe M, MacDonald-Hull SP, Potts ED, Crone M, Wilkinson S, Camacho-Martinez F, Jablonska S, Ratnavel R, MacDonald A, Mann RJ, Grice K, Guillet G, Lewis-Jones MS, McGrath H, Seukeran DC, Morrison PJ, Fleming S, Rahman S, Kelsell D, Leigh I, Olpin S, Tomlinson IP (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12:1241–1252
50. Rustin P (2002) Mitochondria, from cell death to proliferation. Nat Genet 30:352–353
51. Enns R, Criddle RS (1977) Investigation of the structural arrangement of the protein subunits of mitochondrial ATPase. Arch Biochem Biophys 183:742–752
52. Larsson NG, Luft R (1999) Revolution in mitochondrial medicine. FEBS Lett 455:199–202
53. Smiraglia DJ, Kulawiec M, Bistulfi GL, Gupta SG, Singh KK (2008) A novel role for mitochondria in regulating epigenetic modification in the nucleus. Cancer Biol Ther 7:1182–1190
54. Park SY, Chang I, Kim J, Kang SW, Park S, Singh K, Lee M (2004) Resistance of mitochondrial DNA-depleted cells against cell death. J Biol Chem 279:7512–7520
55. Shen J, Platek M, Mahasneh A, Ambrosone CB, Zhao H (2010) Mitochondrial copy number and risk of breast cancer: a pilot study. Mitochondrion 10:62–68
56. Okoh V, Deoraj A, Roy D (2011) Estrogen-induced ROS mediated redox signaling contributes in the development of breast cancer. Biochem Biophys Acta 1815:115–133